HeartWare International, Inc. (Nasdaq: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, ...

A clinical trial of HeartWare's newest LVAD has been paused, at the same time that St. Jude Medical's HeartMate 3 has won CE Mark. Nancy Crotti HeartWare International has put a clinical trial of its ...

Shares of HeartWare International Inc. HTWR plunged more than 20% to close at $35.21 on Oct 13, after the company disclosed in an 8K filing that it may not resume patient enrollment for the MVAD ...

LOUISVILLE, Ky., Sept. 9, 2011 -- Data presented today at the 19th Congress of the International Society for Rotary Blood Pumps (ISRBP) demonstrated that the HeartWare MVAD® Pump attained the ...

HeartWare International said today that it’s launching a clinical trial aimed at winning CE Mark approval in the European Union for its next-generation MVAD implantable heart pump. The prospective, ...

Ventricular assist devices manufacturer Heartware International Inc. HTWR believes that its new miniaturized ventricular assist device (MVAD) will help it gain market traction in 2015 and beyond. MVAD ...

2016 is off to a slow start for MVAD, the next-generation left ventricular assist device (LVAD) being developed by HeartWare. After the company paused the MVAD CE Mark trial last fall and started ...

Thinly traded micro cap HeartWare International (NASDAQ:HTWR-26.3%) slumps in early trading on increased volume in response to its progress report on its left ventricular assist device MVAD System ...

Shares of HeartWare International Inc. HTWR plunged more than 20% to close at $35.21 on Oct 13, after the company disclosed in an 8K filing that it may not resume patient enrollment for the MVAD ...

- The MVAD System is a versatile, miniaturized and hematologically advanced circulatory assist system designed for full-support of patients with advanced heart failure - FRAMINGHAM, Massachusetts, ...

- Successful GLP study provides confidence to progress to human clinical trials - Data presented today at the 19th Congress of the International Society for Rotary Blood Pumps (ISRBP) demonstrated ...

- The MVAD System is a versatile, miniaturized and hematologically advanced circulatory assist system designed for full-support of patients with advanced heart failure - The MVAD Pump is a heart pump ...